We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
AUM
$1.68B
AUM Growth
+$438M
Cap. Flow
+$400M
Cap. Flow %
23.75%
Top 10 Hldgs %
20.89%
Holding
201
New
45
Increased
64
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$36.6M
2
RBA icon
RB Global
RBA
+$22.3M
3
DORM icon
Dorman Products
DORM
+$20.1M
4
WKC icon
World Kinect Corp
WKC
+$19.6M
5
MNRO icon
Monro
MNRO
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 18.39%
2 Industrials 16.53%
3 Technology 14.8%
4 Financials 13.66%
5 Consumer Discretionary 13.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGLT
176
DELISTED
Egalet Corporation
EGLT
$731K 0.04%
95,612
ULTI
177
DELISTED
Ultimate Software Group Inc
ULTI
$630K 0.04%
3,456
-30,300
-90% -$6.07M
EXPO icon
178
Exponent
EXPO
$3.21B
$624K 0.04%
20,692
ATRA icon
179
Atara Biotherapeutics
ATRA
$74.3M
$600K 0.04%
1,692
-1,527
-47% -$647K
SNDX icon
180
Syndax Pharmaceuticals
SNDX
$1.76B
$596K 0.04%
83,172
-39,964
-32% -$438K
MELI icon
181
Mercado Libre
MELI
$92.8B
$589K 0.04%
3,773
GGG icon
182
Graco
GGG
$13.5B
$549K 0.03%
19,809
TTC icon
183
Toro Company
TTC
$9.35B
$549K 0.03%
9,820
BFAM icon
184
Bright Horizons
BFAM
$3.89B
$543K 0.03%
7,760
WINA icon
185
Winmark
WINA
$1.27B
$429K 0.03%
+3,400
New +$385K
BLKB icon
186
Blackbaud
BLKB
$2.1B
$425K 0.03%
6,646
ESPR
187
DELISTED
Esperion Therapeutics
ESPR
$267K 0.02%
21,325
ENSV
188
DELISTED
Enservco Corp.
ENSV
$235K 0.01%
28,000
ATYR
189
aTyr Pharma
ATYR
$49.2M
$205K 0.01%
6,808
-8,460
-55% -$347K
BDSI
190
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$83K ﹤0.01%
47,517
-132,900
-74% -$271K
APAM icon
191
Artisan Partners
APAM
$3.06B
-84,495
Closed -$2.3M
ILMN icon
192
Illumina
ILMN
$29.3B
-10,560
Closed -$1.87M
LCII icon
193
LCI Industries
LCII
$2.57B
-105,493
Closed -$10.3M
MYGN icon
194
Myriad Genetics
MYGN
$304M
-123,800
Closed -$2.55M
STRT icon
195
STRATTEC Security
STRT
$363M
-20,091
Closed -$709K
TARA icon
196
Protara Therapeutics
TARA
$230M
-4,055
Closed -$1.51M
VZ icon
197
Verizon
VZ
$195B
-88,319
Closed -$4.59M
DRNA
198
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-128,926
Closed -$758K
MDSO
199
DELISTED
Medidata Solutions, Inc.
MDSO
-28,198
Closed -$1.57M
TYPE
200
DELISTED
Monotype Imaging Holdings Inc.
TYPE
-84,495
Closed -$1.87M

Similar funds

Tiverton Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Tiverton Asset Management held 201 positions worth $1.68B, up 35% from $1.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tiverton Asset Management deployed $400M of net new capital in Q4 2016, opening 45 new positions and adding to 64 existing holdings. Its largest new stake was Pediatrix Medical: 562,005 shares worth $37.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Ultimate Software Group Inc, an estimated $6.07M trimmed.

  • Tiverton Asset Management's largest Q4 2016 buy was Pediatrix Medical: 562,005 shares worth $37.5M.
  • Tiverton Asset Management added most to Kraft Heinz in Q4 2016, an estimated $5.46M increase.
  • Tiverton Asset Management's biggest Q4 2016 reduction was Ultimate Software Group Inc, cutting an estimated $6.07M.
  • Tiverton Asset Management fully exited LCI Industries in Q4 2016, selling an estimated $10.3M.
  • Tiverton Asset Management's ten largest holdings make up 21% of its $1.68B portfolio in Q4 2016.
  • Tiverton Asset Management opened 45 new positions and closed 11 in Q4 2016.
  • Tiverton Asset Management's portfolio value rose 35% quarter-over-quarter to $1.68B.

Based on Tiverton Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.